Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erika Vacchelli

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Oncoimmunology|April 9, 2016
Immunosurveillance in esophageal carcinoma: The decisive impact of regulatory T cellsErika Vacchelli, Michaela Semeraro, Julien Adam, et al.
Oncoimmunology|December 15, 2018
Systemic autophagy in the therapeutic response to anthracycline-based chemotherapyFrancesca Castoldi, Erika Vacchelli, Laurence Zitvogel, et al.
Oncoimmunology|February 1, 2014
Trial Watch: Lenalidomide-based immunochemotherapyMichaela Semeraro, Erika Vacchelli, Alexander Eggermont, et al.
Oncoimmunology|September 14, 2020
Contribution of annexin A1 to anticancer immunosurveillanceElisa Elena Baracco, Gautier Stoll, Peter Van Endert, et al.
Oncoimmunology|July 4, 2012
Trial Watch: Immunostimulatory cytokinesErika Vacchelli, Lorenzo Galluzzi, Alexander Eggermont, et al.
Oncoimmunology|September 28, 2013
Trial Watch: Immunostimulatory cytokinesErika Vacchelli, Alexander Eggermont, Wolf Hervé Fridman, et al.
Oncoimmunology|September 16, 2020
Trial Watch: experimental TLR7/TLR8 agonists for oncological indicationsGiorgio Frega, Qi Wu, Julie Le Naour, et al.
Oncoimmunology|October 2, 2013
Trial Watch: Toll-like receptor agonists for cancer therapyErika Vacchelli, Alexander Eggermont, Catherine Sautès-Fridman, et al.
Oncoimmunology|March 14, 2013
Trial watch: Monoclonal antibodies in cancer therapyErika Vacchelli, Alexander Eggermont, Jérôme Galon, et al.
Oncoimmunology|July 30, 2013
Trial watch: Oncolytic viruses for cancer therapyErika Vacchelli, Alexander Eggermont, Catherine Sautès-Fridman, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Oncoimmunology|April 9, 2016
Immunosurveillance in esophageal carcinoma: The decisive impact of regulatory T cellsErika Vacchelli, Michaela Semeraro, Julien Adam, et al.
Oncoimmunology|December 15, 2018
Systemic autophagy in the therapeutic response to anthracycline-based chemotherapyFrancesca Castoldi, Erika Vacchelli, Laurence Zitvogel, et al.
Oncoimmunology|February 1, 2014
Trial Watch: Lenalidomide-based immunochemotherapyMichaela Semeraro, Erika Vacchelli, Alexander Eggermont, et al.
Oncoimmunology|September 14, 2020
Contribution of annexin A1 to anticancer immunosurveillanceElisa Elena Baracco, Gautier Stoll, Peter Van Endert, et al.
Oncoimmunology|July 4, 2012
Trial Watch: Immunostimulatory cytokinesErika Vacchelli, Lorenzo Galluzzi, Alexander Eggermont, et al.
Oncoimmunology|September 28, 2013
Trial Watch: Immunostimulatory cytokinesErika Vacchelli, Alexander Eggermont, Wolf Hervé Fridman, et al.
Oncoimmunology|September 16, 2020
Trial Watch: experimental TLR7/TLR8 agonists for oncological indicationsGiorgio Frega, Qi Wu, Julie Le Naour, et al.
Oncoimmunology|October 2, 2013
Trial Watch: Toll-like receptor agonists for cancer therapyErika Vacchelli, Alexander Eggermont, Catherine Sautès-Fridman, et al.
Oncoimmunology|March 14, 2013
Trial watch: Monoclonal antibodies in cancer therapyErika Vacchelli, Alexander Eggermont, Jérôme Galon, et al.
Oncoimmunology|July 30, 2013
Trial watch: Oncolytic viruses for cancer therapyErika Vacchelli, Alexander Eggermont, Catherine Sautès-Fridman, et al.
Pageof 9